Brief: Kamada Reports Q3 Loss Of 2 Cents Per Share

Kamada

22/11/2021 12:19

Nov 22 (Reuters) - Kamada Ltd  KMDA.TA :
    * KAMADA REPORTS THIRD QUARTER AND FIRST NINE MONTHS OF 2021
FINANCIAL RESULTS, AND STRATEGIC TRANSFORMATIONAL ACQUISITION OF
A PORTFOLIO OF FOUR FDA-APPROVED PLASMA-DERIVED HYPERIMMUNE
COMMERCIAL PRODUCTS
    * Q3 LOSS PER SHARE $0.02
    * Q3 REVENUE $23 MILLION

Source text for Eikon:  ID:nGNXbrJDk5 
Further company coverage:  KMDA.TA 

 ((Reuters.Briefs@thomsonreuters.com;))